🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 92764N102
- Market Cap
- Large Cap
- IPO
- 10/11/2019 · $20.00/share
Business: Vir Biotechnology, Inc. is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The Company's approach begins with identifying the limitations of the immune system in combating a particular pathogen, the vulnerabilities of that pathogen and the reasons why previous approaches have failed. Then the Company brings to bear powerful technologies that they believe, individually or in combination, will lead to effective therapies.
Company Contact
- CEO
- Marianne De Backer
- CFO
- Jason O’Byrne
- Headquarters
- 1800 Owens Street, Suite 900, San Francisco, CA 94158
- Phone
- 415-906-4324
- Investor Relations
- Patrick O'Brien · 628-232-0248 · pobrien@vir.bio